Eurofins Transplant Genomics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Eurofins Transplant Genomics is a biotechnology research company focused on improving organ transplant outcomes through noninvasive, genomics-guided monitoring. Its tests center on serial blood-based assessments to help clinicians tailor immunosuppression therapy for transplant recipients, reducing reliance on invasive procedures. In 2022 the company announced the commercial availability of TruGraf Liver, a blood-based test designed to guide immunosuppression management for liver transplant patients.

Based in Framingham, Massachusetts, the company is a small to mid-sized biotechnology firm within the Eurofins Scientific group, following its 2019 acquisition. Its offerings target transplant centers and healthcare providers involved in organ transplantation, providing noninvasive genomic tools to support monitoring and clinical decision-making in patient care.

Sign up for free to view info

Company overview Employee directory